Cargando…
Preventing Hepatitis B Reactivation During Anti‐CD20 Antibody Treatment in the Veterans Health Administration
Hepatitis B virus (HBV) reactivation may occur with high risk immunosuppression, such as anti‐cluster of differentiation (CD)20 antibodies (Abs). Appropriate HBV prophylaxis during anti‐CD20 Ab therapy averts hepatitis, chemotherapy disruption, and death. Serologic evidence of prior HBV exposure is...
Autores principales: | Jasmine Bullard, A., Cunningham, Francesca E., Volpp, Bryan D., Lowy, Elliott, Beste, Lauren A., Heron, Bernadette B., Geraci, Mark, Hammond, Julia M., LaPlant, Kourtney, Stave, Elise A., Turner, Marsha J., O’Leary, Meghan C., Kelley, Michael J., Hunt, Christine M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6128236/ https://www.ncbi.nlm.nih.gov/pubmed/30202826 http://dx.doi.org/10.1002/hep4.1238 |
Ejemplares similares
-
Practice Model: Establishing and Running an Oral Chemotherapy Management Clinic
por: May, Paige, et al.
Publicado: (2017) -
Gonorrhea and Chlamydia Testing and Case Rates Among Women Veterans in the Veterans Health Administration
por: Keddem, Shimrit, et al.
Publicado: (2022) -
1353. Gonorrhea and Chlamydia Testing and Case Rates Among Women Veterans in the Veterans Health Administration
por: Keddem, Shimrit, et al.
Publicado: (2021) -
168. Testing, Diagnosis, and Incidence of Sexually Transmitted Infections Among People with Substance Use Disorders in the Veterans Health Administration, 2019
por: Villamagna, Holly, et al.
Publicado: (2021) -
Use of targeted therapies for advanced renal cell carcinoma in the Veterans Health Administration
por: Aspinall, Sherrie L., et al.
Publicado: (2019)